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Edited by Judit Ova´diAbstract Presence of isolated b or bc domains of streptokinase
(SK) increased the catalytic activity of staphylokinase (SAK)–
plasmin (Pm) complex up to 60%. In contrast, fusion of SK b
or bc domains with the C-terminal end of SAK drastically re-
duced the catalytic activity of the activator complex. The
enhancement eﬀect mediated by b or bc domain on Pg activator
activity of SAK–Pm complex was reduced greatly (45%) in the
presence of isolated kringles of Pg, whereas, kringles did not
change cofactor activity of SAK fusion proteins (carrying b or
bc domains) signiﬁcantly. When catalytic activity of SAK–
microPm (catalytic domain of Pm lacking kringle domains) com-
plex was examined in the presence of isolated b and bc domains,
no enhancement eﬀect on Pg activation was observed, whereas,
enzyme complex formed between microplasmin and SAK fusion
proteins (SAKb and SAKbc) displayed 50–70% reduction in
their catalytic activity. The present study, thus, suggests that
the exogenously present b and bc interact with Pg/Pm via kringle
domains and elevate catalytic activity of SAK–Pm activator
complex resulting in enhanced substrate Pg activation. Fusion
of b or bc domains with SAK might alter these intermolecular
interactions resulting in attenuated functional activity of SAK.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Staphylokinase; Streptokinase; Plasminogen;
Kringles; Microplasmin; Plasminogen activation1. Introduction
Invasive human pathogens have evolved plasminogen acti-
vators, such as staphylokinase (SAK) and streptokinase (SK)
which are not enzymes themselves but form bimolecular 1:1
complex with human plasmin (Pm) or plasminogen (Pg) that
in turn catalyzes the conversion of free Pg into Pm [1,2]. In hu-
man plasma, Pm circulates as a proenzyme Pg, which is acti-
vated by proteolytic cleavage of Arg561–Val562 peptide bond
[3,4]. Human Pg contains catalytically active protease domain
and ﬁve kringle domains that serve as functional binding loci
for other plasma proteins [5,6]. The activation of truncatedAbbreviations: SAK, staphylokinase; SK, streptokinase; Pg, plasmino-
gen; lPg, micro-plasminogen, i.e., the catalytic domain of plasminogen;
SKa, SKb and SKc, the amino-terminal, middle and carboxy-terminal
domains of streptokinase; SAKb and SAKbc, SAK carrying b and bc
domains of SK, respectively
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and protease domain) and microplasminogen (lPg, carrying
only protease domain), is slower than the full length Pg [7],
suggesting a role for kringle domains in the Pg activation
process.
Although, SAK and SK display basic similarities in their
function as a cofactor, certain key diﬀerences are there in their
molecular mechanism of Pg activation. In contrast with SK
which can form activator complex with Pg or Pm, SAK is
strictly dependent on Pm to form activator complex [1,8].
The generation of Pg activation potential in SAK proceeds
via Pm-mediated removal of its 10 amino-terminal amino acid
residues [9–11]. Additionally, SAK–Pm complex, but not the
SK–Pm complex is inactivated by a2-antiplasmin [2,12–15].
Another property that distinguish SAK from SK is that the
presence of ﬁbrin degradation products greatly enhance the
Pg activation potential of SAK, probably by altering the con-
formation of Pg and making it more suitable for SAK medi-
ated Pg activation. Functionality of SK does not change
signiﬁcantly under similar condition [16].
The structure determination of ternary complex of lPm [15]
with SAK and of a binary complex of lPm with SK [17],
together with molecular modeling and mutagenesis studies
[9–11,18,19] have provided novel insight into the molecular as-
pects of co-factor mediated Pg activation. Comparison of
structures reveals that SK essentially surrounds the catalytic
domain of Pm, whereas, the much smaller SAK contacts only
one side. The extensive intermolecular contact allows SK to
form a tighter and more stable bimolecular complex with Pg/
Pm as compared to SAK. In a model hypothesized for the
SK–Pg complex, Loy et al. [20] suggested that each domain
of SK could be assigned to a distinct function. Whereas,
SKa domain assists in proper substrate pre-orientation and
presentation to the active site of the enzyme, SKb domain pro-
vides a further substrate-anchoring site that also modulates the
interaction of Pm with macromolecular inhibitors. Addition-
ally, SKb has been shown to interact with kringle domain of
substrate Pg [21]. SK c domain has been proposed to partici-
pate in contact activation of Pg by SK [17].
At present, SAK is the smallest known single domain Pg
activator that exhibits close three-dimensional structural simi-
larity with the a domain of SK including similar b-grasp fold-
ing characteristics and it has been suggested that SAK and
SKa domain perform similar functions in the Pg activator
complex [22]. Both SAK and SKa domain bind Pm near the
active site without inducing signiﬁcant conformational changes
in the active site residues directly. Along with partner Pg,
these cofactors provide a template onto which the substrateblished by Elsevier B.V. All rights reserved.
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resulting in the optimized presentation of the Pg activation
loop at the active center of the complex [15,17]. However, in
contrast to SAK, SKa domain alone exhibits drastically re-
duced Pg activation capability [20]. Looking into the domain
cooperativity in manifesting the Pg activation process, it be-
comes logical to test the function of various SK domains in
modulating the Pg activator activity of SAK. The present
study addresses the question, whether it is possible to generate
progressive increase in cofactor activity of SAK by incorporat-
ing domain motif of SK. As a test in this direction, we overex-
pressed individual domains of SK and its two domain
combination and also engineered b and c domains of SK to
create chimeric SAK carrying two domain (SAK + b) or three
domain structure (SAK + bc) and explored the implications of
individual domains of SK on generation of Pg activator com-
plex and processing of substrate Pg.0 2 4 6 8 10
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Fig. 1. Pg activation by SAK in the presence of SK domains. Human
Pg (1.5 lM) was incubated with SAK (5 nM) in the presence various
SK domains (5 M) along with 1.2 mM Chromozym PL at 25 C in
50 mMM Tris–HCl/100 mM NaCl, pH 7.5, containing 0.1% BSA and
0.01% Tween 80. The rate of Pm generation was monitored at 405 nm
at diﬀerent time intervals.2. Materials and methods
2.1. Bacterial strains, plasmids, and reagents
S. aureus was used for retrieving the gene (sak) encoding SAK as de-
scribed previously [11]. Plasmid vectors, pBS KS+ (Stratagene, Ger-
many) and pET9b (Promega, WI, USA), were utilized for the gene
cloning and expression purposes. All restriction and DNA modifying
enzymes were obtained from New England Biolabs (Beverly, USA).
Chromozym PL and human Pg were purchased from Boehringer
Mannheim (Germany). Puriﬁed kringle domains (K1 + K2 + K3) of
plasminogen were obtained from Sigma. Human Pg was isolated from
fresh frozen plasma using Lysine–Sepharose chromatography [23] and
lPg was prepared by the method of Wu et al. [24].
2.2. Cloning, expression, and puriﬁcation of recombinant proteins
The cloning and expression of individual b, c, and bc domains of SK
were carried out essentially as described earlier [25]. Recombinant
SAK, b and c domains were puriﬁed from the cell extract of Escherchia
coli following two chromatographic steps using DEAE–Sepharose and
Phenyl–Sepharose following the published procedures [11,21,25,26].
SAKb fusion was puriﬁed in single step using DEAE–Sepharose and
was eluted in 50 mM NaCl in 20 mM Tris–HCl, pH 7.5, whereas,
SAKbc fusion protein was puriﬁed by two chromatographic steps.
In the ﬁrst step, DEAE–Sepharose was used and protein was eluted
at 100 mM NaCl in Tris–HCl, pH 7.5. Partially puriﬁed protein was
then loaded on Phenyl–Sepharose column in 500 mM NaCl in
20 mM sodium phosphate buﬀer, pH 7.2, and eluted in distilled water.
2.3. Plasminogen activation by SAK in the presence of various SK
domains
To check the eﬀect of SK domains on Pg activation property of
SAK, 5 nM of SAK and 1.5 lM of Pg were mixed with 5 lM of var-
ious SK domains (b, c, and bc) in a quartz cuvette carrying 1.0 mM
Chromozym PL in 50 mM Tris–HCl, pH 7.5, containing 0.1% BSA,
100 mMNaCl, and 0.01% Tween 80 [27,28]. The change in absorbance
at 405 nm was then measured as a function of time in a Shimadzu (UV-
1601) spectrophotometer at 25 C. In another experiment precomplex
of 1.5 lM of Pg was formed with 5 nM of SAK along with diﬀerent
concentration of SK domains at 37 C for 5 min and then Pg activation
was studied by monitoring the change in the absorbance at 405 nm.
Active site generation within the activator complex was determined
from the burst of p-nitrophenol, using molar absorption coeﬃcient
of 16700 M1 cm1 [29].
2.4. Determination of steady-state kinetic parameters of Pg activation by
SAK in presence of SK domains
To calculate the steady-state kinetic constants of Pg activation by
SAK in the presence of SKb and bc domains, equimolar mixtures of
SAK (1.5 lM), and Pg (1.5 lM) were preincubated along with 3-fold
molar excess of SKb or bc domains in 50 mM Tris–HCl, pH 7.5, con-taining 0.1% BSA, 100 mM NaCl, and 0.01% Tween 80 at 37 C for
5 min to generate the activator complex. The activator complexes
(5 nM), thus, formed, were mixed with diﬀerent concentrations of Pg
(1–10 lM) and 1.0 mM Chromozym PL. The change in absorbance
at 405 nm was measured as a function of time in Shimadzu (UV–
1601) spectrophotometer. Cleavage of substrate Pg to Pm by SAK
was monitored by SDS–PAGE in the presence of SKb and bc do-
mains. For that, equimolar amounts of SAK and Pg (1.5 lM each)
were incubated with 3-fold molar excess of SKb or bc domains at
15 C in 50 mM Tris–HCl, pH 7.5. At each time point, 7.5 l l aliquot
was removed and analyzed for the conversion of Pg into Pm on 12%
SDS–PAGE. To analyze Pg cleavage by SAKb and SAKbc proteins,
1.5 lM Pg was incubated with 1.5 lM of respective proteins at 25 C.3. Results
3.1. Pg activation by SAK in combination with single and two
domain components of SK
Since, SAK has close structural similarity with a domain of
SK, it prompted us to investigate how b and c domains of SK
would aﬀect Pg activation function of SAK. DNA sequences
encoding b and c domains individually or their two-domain
combination were cloned, expressed and their corresponding
recombinant proteins were puriﬁed from the cell extract of
E. coli. Pg activator activities of individual b and c domains
of SK were less than 0.05% of total activator activities of SK
and SAK. Similarly, Pg activator activities of two-domain
component, bc, were highly attenuated and exhibited less that
1% of total Pg activator activity of SK and SAK. When indi-
vidual b and c domains or their two-domain combinations
were added in excess directly to the reaction mixture carrying
catalytic amounts of SAK and Pg, no distinct change in Pg
activation proﬁle was observed (Fig. 1). However, when Pg
was preincubated at 37 C for 5 min with increasing concentra-
tions of individual b and c domains as well as their two-do-
main combination to generate a complex and then added to
reaction mixture carrying 5 nM of SAK to study the Pg activa-
tion, a gradual increase in SAK mediated Pg activation was
observed. Fig. 2(a)–(d) exhibits time dependent activation of
Pg by SAK in the presence of preformed complex between
Pg and various domains of SK. A concentration dependent in-
Table 1
Kinetic constants for the Pg activation properties of equimolar
complexes of SAK and Pg in the presence of SK domains
Bimolecular
complex
Km
(lM)
kcat
(s1)
kcat/Km
(s1 lM1)
SAK–Pm 2.5 ± 0.12 2.0 ± 0.1 0.8
SAK + b–Pm 1.5 ± 0.10 2.9 ± 0.08 1.99
SAK + bc–Pm 1.3 ± 0.12 3.2 ± 0.12 2.46
The results are means ± S.E.M. of three determinations.
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Fig. 2. Pg activation by SAK in the presence of SKb (a), c (b), b + c (c) and bc (d) domains. Human Pg (1.5 lM) was incubated with increasing
concentrations of SKb or bc domains at 37 C. After 5 min, SAK (5 nM) was added to Pg-SK domain complex along with 1.2 mM Chromozym PL
at 25 C in 50 mM M Tris–HCl/100 mM NaCl, pH 7.5, containing 0.1% BSA and 0.01% Tween 80. The rate of Pm generation was monitored at
405 nm at diﬀerent time intervals.
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generated between Pg and b domain of SK. In contrast, c do-
main of SK did not show any distinct eﬀect on SAK mediated
Pg activation. Addition of b and c domain separately to form
complex with Pg exhibited the Pg activation pattern by SAK
similar to that observed with b domain alone. These observa-
tions suggested that c domain might not be interacting eﬀec-
tively with Pg like b domain. Interestingly, when two domain
combination, bc, was incubated with Pg, a sharp increase in
Pg activation by SAK was observed with increasing concentra-
tion. This increase in Pg activation was up to 4-fold higher in
the initial stages as compared to complex formed between Pg
and separate b and c domains, suggesting that integration of
b and c domain is able to enhance the Pg activator activity
of SAK–Pg activator complex synergistically. A time course
study on generation of active site in the substrate Pg by bimo-
lecular complex of SAK–Pm exhibited an initial lag period,
whereas, lag time in active site generation was reduced when
individual b domain or its fusion with c domain was incorpo-
rated along with SAK and Pg, resulting in early appearance of
active site in the activator complex (see supplementary results).
3.2. Kinetic characterization of substrate Pg activation by
activator complex formed between SAK, Pm, and various
SK domains
Since binding of b and bc domains of SK facilitated Pg acti-
vation property of SAK–Pm activator complex, further exper-
iments were carried out to explore the mechanism of this
positive eﬀect exerted by these SK domains by studying thesteady-state kinetics of Pg activation by activator complex gen-
erated by SAK, Pm and various SK domains. The overall acti-
vation pattern of substrate Pg activation by SAK–Pm complex
in the presence of SK domains obeyed the Michaelis–Menten
kinetics and Km of SAK–Pm complex for substrate Pg in the
presence of b and bc domains were 1.47 and 1.3 M, respec-
tively, as compared to 2.5 lM observed for the native SAK–
Pm activator complex, suggesting that the presence of b and
bc domains of SK greatly enhance the aﬃnity of activator
complex towards the substrate Pg that is also evident from
more than 2-fold increase in the catalytic eﬃciency of these
activator complexes (Table 1). We then monitored the cleavage
of substrate Pg to Pm by these activator complexes on SDS–
PAGE to further compare the catalytic eﬃciency of SAK–
Pm activator complex in the presence of b and bc domains.
Conversion of Pg to Pm with respect to time was monitored
by densitometric analysis of protein proﬁle which indicated
that almost 100% Pg was converted to Pm by SAK in the
presence of b and bc domains of SK in less than 5 min,
Fig. 3. Cleavage of Pg by SAK–Pm enzyme complex in the presence of SK domains. Equimolar amounts of SAK or SAK + b/bc and Pg (1.5 lM
each) were mixed in 100 mM Tris–HCl, pH 7.5, and incubated at 15 C for 5 min. At each time point, a 7.5 ll aliquot was removed and analyzed for
the conversion of Pg into Pm by 12% SDS–PAGE. Lane M: Molecular-mass markers; Lane 1: Pg; Lane 2: puriﬁed SAK; Lane 3-6: SAK–Pg reaction
mixtures incubated for 0, 1, 2, and 5 min respectively; Lane 7: puriﬁed SKb and SAK; Lanes 8–11: SAK + b + Pg reaction mixture incubated for 0, 1,
2, 5 min, respectively; Lane: 12 Pg and SKb incubated for 5 min; Lane 13: puriﬁed SAK and SKbc; Lanes 14–16: SAK + bc + Pg reaction mixture
incubated for 0, 1, 2 min, respectively; Lane 17: Pg and SKbc incubated for 2 min. The arrows indicate the cleavage products of Pg to Pm.
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Fig. 4. (a) Pg activation by SAK fusion proteins. Human Pg (1.5 lM)
was incubated with SAK fusion proteins (5 nM) along with 1.2 mM
Chromozym PL at 25 C in 50 mM Tris–HCl/100 mM NaCl, pH 7.5,
containing 0.1% BSA and 0.01% Tween 80. The rate of generation of
Pm was monitored at 405 nm at diﬀerent time intervals. (b) Activation
of substrate Pg by preformed complex of Pg with SAK fusion proteins.
Pg (1.5 lM) and SAK fusion proteins (1.5 lM) were preincubated for
5 min at 37 C in 50 mM Tris–HCl, pH 7.5, containing 100 mM NaCl,
0.1% BSA, and 0.01% Tween 80. This complex was subsequently
diluted (ﬁnal concentration 5 nM) and incubated with Pg (1.5 lM) and
generated Pm activity was measured at diﬀerent time intervals in the
presence of Chromozym PL.
1568 M. Dahiya et al. / FEBS Letters 579 (2005) 1565–1572whereas, SAK alone showed nearly 50% conversion of Pg to
Pm under similar conditions (Fig. 3). These results further con-
ﬁrmed that catalytic eﬃciency of SAK–Pm activator complex
is enhanced in the presence of b and bc domains of SK.
3.3. Construction of chimeric SAK proteins carrying b and c
domains of SK and evaluation of their Pg activation
potential
Since isolated b and bc domains of SK enhanced the cata-
lytic eﬃciency of SAK–Pm activator complex, we further
checked whether fusion of these domains with SAK would
generate a better Pg activator molecule. To check this idea
experimentally, we genetically engineered b and bc domains
to generate chimera of SAK and SK in which b (SAKb) or
bc domains (SAKbc) of SK were fused to the C-terminal re-
gion of SAK. In contrast to enhancement eﬀect observed on
functionality of SAK in the presence of isolated domains of
SK, fusion of these domains with SAK resulted in nearly 10-
fold decrease in Pg activator activities (12 IU/lg) as com-
pared to native SAK (116 IU/lg). The catalytic amount of
SAK induced rapid activation of Pg to Pm resulting in 50%
of Pg activation within 7 min. In contrast, an extended lag
was observed in the initiation of Pg activation by SAKb
(5 min) and SAKbc (7 min) fusion proteins resulting in 50%
Pg activation in about 11 and 13 min, respectively
(Fig. 4(a)). Our earlier results had indicated that the presence
of isolated domains of SK exert several-fold enhancement in
Pg activator activities of SAK–Pm activator complex, there-
fore, we attempted to check whether this attenuated Pg activa-
tor activities of SAK fusion proteins are due to diﬀerence in
generating an eﬃcient activator complex with the partner pro-
tein or due to the alteration in the interaction of SAK fusion
proteins with substrate Pg. Preformed activator complexes
were generated by incubating equimolar mixture of SAKb or
SAKbc with Pg and substrate Pg activation proﬁle of these
complexes were studied. Activation of substrate Pg by pre-
formed activator complex generated by SAK fusion proteins
occurred with a brief lag followed by an exponential phase
(Fig. 4(b)) but overall rate of substrate Pg activation remained
slower than the SAK–Pg activator complex. Interestingly, in
M. Dahiya et al. / FEBS Letters 579 (2005) 1565–1572 1569contrast to the results obtained with direct Pg activation by
SAK fusion proteins, preformed activator complex formed be-
tween SAKbc and Pg resulted in faster activation of substrate
Pg as compared to SAKb–Pg complex. When time course acyl-
ation of substrate Pg active site by SAK fusion–Pm complex
was compared with native SAK, a slight delay in acylation pat-
tern was observed (see supplementary results). These results
provided further evidence that fusion of SK domains with
SAK create constrain in generating an eﬃcient Pg activator
complex as compared to isolated domains of SK.
3.4. Steady-state kinetic parameters of Pg activation by SAK
fusion proteins
Since SAKb and SAKbc were defective in the formation of
eﬃcient activator complex with partner Pg and substrate Pg
activation, kinetics of substrate Pg activation by bimolecular
Pg activator complexes, generated by mixing equimolar ratio
of Pg with SAKb or SAKbc, was studied at diﬀerent concen-
trations of substrate Pg. The overall activation pattern obeyed
Michaelis–Menten kinetics. Interestingly, Km of SAKb and
SAKbc for the substrate Pg was lower than the native SAK
suggesting that SAK fusion proteins have about 1.5-fold
higher aﬃnity for the substrate Pg, however, catalytic eﬃ-
ciency of these chimeric SAK proteins were signiﬁcantly re-
duced (Table 2). This is in variance with the results obtained
when individual domains of SK were provided in trans alongTable 2
Kinetic constants for the Pg activation properties of equimolar
complexes of SAK fusion proteins and Pg
Bimolecular
complex
Km
(lM)
kcat
(s1)
kcat/Km
(s1 lM1)
SAK–Pm 2.5 ± 0.12 2.0 ± 0.1 0.8
SAKb–Pm 1.52 ± 0.10 1.3 ± 0.08 0.85
SAKbc–Pm 1.5 ± 0.11 1.2 ± 0.06 0.8
The results are means ± S.E.M. of three determinations.
Fig. 5. Cleavage of Pg by equimolar complex of Pm with SAK fusion prote
were mixed in 100 mM Tris–HCl, pH 7.5, and incubated at 25 C for 30 min.
conversion of Pg into Pm by 12% SDS–PAGE. Lane M: Molecular-mass ma
mixtures incubated for 0, 1, 2, and 5 min, respectively; Lane 7: puriﬁed SAKb
30 min, respectively; Lane 13: puriﬁed SAKbc; Lanes 14–18: SAKbc + Pg re
arrows indicate the cleavage products of Pg to Pm.with SAK, which exhibited signiﬁcant increase in substrate
Pg interaction and processing. Cleavage of substrate Pg to
Pm by SAK fusion proteins was monitored on SDS–PAGE
to further compare the catalytic eﬃciency of SAKb and
SAKbc with native SAK. Time course study on conversion
of Pg to Pm and densitometric analysis of the protein proﬁle
indicated that almost 100% Pg was converted to Pm by SAK
within 5 min, whereas, SAKb and SAKbc took more than
15 min for complete processing of Pg (Fig. 5), indicating that
the cleavage of Pg to Pm by activator complex formed by
SAKb and SAKbc with Pm was signiﬁcantly slower than the
native SAK.
3.5. Eﬀect of kringle (K1 + K2 + K3) domains on the activation
of Pg by SAK in the presence of SKb/bc domains
Instead of showing increased Pg activation activity upon
fusion with SK domains, SAK indeed exhibited signiﬁcant
reduction in its native Pg activator activity indicating that
fused SK domains are interacting with Pg in diﬀerent mode
than isolated SK domains. Along with the catalytic domain,
SKb domain is known to have aﬃnity for kringle domains
of Pg [21]. Pg activation by SAK in the presence of SK do-
mains was studied to check for any interference by kringle
domains. Presence of kringle domains showed up to 45%
reduction in Pg activation by SAK in the presence of SKb/
bc domains (Fig. 6). In contrast, SAK fusion proteins, SAKb
and SAKbc, exhibited only marginal change (nearly 20%
inhibition) in the Pg activation in the presence of kringle
structure, similar to native SAK protein. Since, SAK also car-
ries the site for interaction with kringle domains [30], level of
inhibition on Pg activation activity of SAK and SAK fusion
proteins may be due to interference of kringles with SAK and
not with SK domains. Drastic inhibition of Pg activation activ-
ity of SAK by puriﬁed kringles of Pg in the presence of isolated
SK domains, suggests that free kringles are blocking the opti-
mal interactions of isolated SK domains with Pg/Pm but have
no eﬀect when these domains are integrated with SAK.ins. Equimolar amounts of SAK or SAK fusion and Pg (1.5 lM each)
At each time point, a 7.5 ll aliquot was removed and analyzed for the
rkers; Lane 1: Pg; Lane 2: puriﬁed SAK; Lanes 3–6: SAK–Pg reaction
; Lane 8-12: SAKb + Pg reaction mixture incubated for 0, 5, 10, 15, and
action mixture incubated for 0, 5, 10, 15, and 30 min, respectively; The
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Fig. 6. Eﬀect of kringle domains of human Pg on Pg activation by
SAK in the presence of SK domains. Human Pg (1.5 lM) was
incubated with SAK (5 nM) and 5 lM of SKc/SKbc or SAK fusion
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The rate of Pm generation was monitored at 405 nm.
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Fig. 7. (a) lPg activation by SAK in presence of isolated SK b and bc
domains. Human lPg (1.5 lM) or Pg was incubated with SAK (5 nM)
in the presence of 5 lM of SKb or SKbc along with 1.2 mM
Chromozym PL at 25 C in 50 mM Tris–HCl/100 mM NaCl, pH 7.5,
containing 0.1% BSA and 0.01% Tween 80. The rate of Pm generation
was monitored at 405 nm. (b) lPg activation by SAKb and SAKbc.
Equimolar mixture of human lPg (1.5 lM) or Pg was incubated with
each SAK fusion proteins (5 nM) for 5 min at 37 C to generate
enzyme complex. The rate of Pm generation was monitored at 405 nm
after adding substrate Pg along with Chromozym PL (1.2 mM) at
25 C in 50 mM Tris–HCl/100 mM NaCl, pH 7.5, containing 0.1%
BSA and 0.01% Tween 80.
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domains
Since inhibitory eﬀect of free kringle domains of Pg was
more pronounced on the Pg activation by SAK in the presence
of isolated SK, it is quite possible that b and bc domains are
interacting with Pg/Pm via kringle domains. To check this pos-
sibility, we studied the functional property of SAK using lPg
in the presence of isolated SK domains. For this experiment,
1.5 lM of lPg was incubated for 5 min at 37 C with 3-fold
molar excess of b or bc domains and after incubation, 5 nM
of SAK was added and amidolytic activity of lPg was moni-
tored using Chromozym PL. As compared to Pg, where cofac-
tor activity of SAK was increased up to 75%, when lPg was
used, isolated SK domains failed to alter the cofactor activity
of SAK (Fig. 7(a)). These results provide further support to the
idea that isolated SK domains increase Pg activation activity
of SAK by interacting with Pg via kringle domains.
3.7. Functional characteristics of lPm-SAKb and lPm-SAKbc
activator complex
To evaluate the involvement of kringle structure of Pg in
modulating the functionality of SAK fusion proteins, we
further compared Pg activation characteristics of bimolecular
complex of SAK fusion proteins generated along with plas-
min or microplasmin (kringle less plasmin). Time course
study on activation of substrate plasminogen by preformed
SAKb–microplasmin and SAKbc–microplasmin enzyme
complex indicated nearly 70% and 50% reduction, respec-
tively, in Pg activation as compared to SAK–microplasmin
complex. More or less similar reduction in substrate Pg acti-
vation was observed, when enzyme complex was formed
between SAK fusion proteins and plasmin (Fig. 7(b))
suggesting that fusion of b and c domains of SK with
SAK interfere with optimal interaction SAK with its partner
protein irrespective of the presence or absence of kringle
domains in partner protein. These results clearly indicate
that the b andc domains in SAK fusion proteins are not
interacting with kringles as has been observed in the case
of isolated SK domains.4. Discussion
SAK is the smallest known, single domain Pg activator that
exhibits close similarity with the a domain of multi-domain Pg
activator, SK. SAK and a domain of SK perform similar func-
tion in a Pg activator complex through generating intermolec-
ular contacts between partner Pg/Pm and substrate Pg,
whereas, b and c domains of SK target Pg region diﬀerent
from where SK a domain and SAK bind [15,17]. Unlike
SAK, SKa domain is not fully functional as a Pg activator
and requires integration of both b and c domains to induce
optimal Pg activation capability in full length SK molecule
[20,31]. Structural elements required for SAK versus SK mech-
anism of Pg activation and contribution of domain interac-
tions in bringing distinct functional diﬀerences between these
two Pg activators are not clearly understood at present. In
the present work, ability of the diﬀerent domains of SK, to
act synergistically with SAK during Pg activation, has been
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with c domain of SK, bring dramatic increase (up to 60%) in
Pg activation potentiality of SAK, whereas, c domain of SK
alone has no eﬀect on Pg activation by SAK. Since b domain
of SK carry high aﬃnity binding site for Pg that does not over-
lap with SAK, it is possible that both b and bc domains com-
bine with the partner Pm along with SAK and restructure the
activation complex to a conformation best suited for the Pg
activation, resulting in its enhanced catalytic activity. This is
supported by the fact that the time course exposure of active
site in substrate Pg by SAK–Pm activator complex formed
along with b or bc domains of SK reduced the lag period for
the active site generation. It has been contended that in SK,
a domain provides the activator complex with the function
of substrate Pg recognition, whereas SKc and bc are capable
of inducing Pg catalytic activity in the activator complex
[22]. Although, presence of isolated SKc domain does not have
any additive enhancement eﬀect on catalytic activity of
SAK–Pm activator complex, two-domain structure of b and
c domain ampliﬁes the catalytic eﬃciency of activator complex
better than SKb alone.
Surprisingly, in contrast to isolated domains, fusion of b and
bc domains along with SAK, results in drastic reduction in Pg
activation potential of SAK suggesting that integration of
these SK domains is generating some constrain in the fusion
protein due to which SAK is not able to display its native
cofactor activity eﬃciently. Although, Km of SAK–Pm com-
plex for substrate Pg remained same when SK domains were
either fused or provided in trans, catalytic activity of SAK fu-
sion–Pm complex was drastically attenuated. This was also re-
ﬂected by the increase in lag period for the exposure of active
site in substrate Pg by SAK fusion–Pm activator complex. No
secondary structure alterations were observed upon in frame
fusion of SK domains with SAK as CD spectrum of SAKbc
fully overlapped with that of SK (given as supporting data).
Overall results from biochemical characterization of SAK fu-
sion proteins indicate that the substrate Pg processing by
SAKb or SAKbc complex with Pm is signiﬁcantly slow after
fusion.
Drastic diﬀerence in the behavior of free SK domains and
after their fusion with SAK towards the cofactor activity of
SAK suggests that intermolecular interaction between Pg
and isolated b and bc domains of SK may be quite diﬀerent.
To get some insight into the mechanism by which isolated
SKb/bc domains are facilitating the Pg activation by SAK,
possible binding sites for b or bc domains in Pg were analyzed
in the earlier reports [17,21].
Although, crystal structure of SK and lPm complex showed
only few intermolecular contacts between SKb domain and
lPm in the activator complex [17], recent biochemical studies
on SK have implicated that a positively charged surface ex-
posed loop of b domain forms a critical interaction with krin-
gle domain of substrate Pg [21]. It is well established that ﬁbrin
ampliﬁes the Pg activation activity of SAK by changing the
conformation of Pg via kringle domain mediated intermolecu-
lar interactions. Addition of puriﬁed kringle domains of Pg,
inhibited the Pg activator activity of SAK in the presence of
isolated SK domains to a greater extent as compared to cofac-
tor activity of SAK and SAK fusion proteins, suggesting that
instead of interacting with Pg kringle domains, SKb and bc
domains are interacting largely with free kringle domains
and, therefore; failed to display their positive eﬀect on Pg acti-vation activity of SAK. As free kringles can interfere with
SAK as well as with isolated SKb domain, percentage inhibi-
tion of SAK cofactor activity was more pronounced when iso-
lated SK domains were used. Low level of inhibition in case of
SAK fusion protein in the presence of isolated kringle domains
suggest that SK domains are not interacting eﬃciently with
kringle domains of Pg when these are integrated with SAK.
Studies on Pg activation by SAK in the presence of SK do-
mains and puriﬁed kringle domains suggest that isolated SK
domains may be amplifying the cofactor activity of SAK
mainly by kringle mediated interaction with Pg. Interaction
of isolated SK domains with kringle domains may restructure
Pg, making it a better substrate for SAK mediated activation
process. This hypothesis was supported by studies on lPg acti-
vation by SAK in the presence of isolated SKb and bc do-
mains, whereas isolated SK domains failed to alter the
cofactor activity of SAK for lPg. Pg activation by the activa-
tor complex formed between SAK fusion proteins along with
plasmin or microplasmin exhibited more or less similar level
of reduction in cofactor activity with respect to activator
complex generated between SAK along with plasmin or micro-
plasmin.
The present study, thus, demonstrates that isolated b and bc
domains of SK interact with Pg and increase the cofactor
activity of SAK. The enhanced Pg activation activity of SAK
in the presence of isolated domains of SK involves their inter-
action with Pg that at least, in part is mediated via the kringle
structures. Extended intermolecular interaction between Pg
and isolated SK domains presumably reconﬁgures Pg and en-
hance the substrate Pg activation by activator complex. Fusion
of b and bc domains of SK with SAK alters these favorable
interactions of SK domains with Pg. Although, all three do-
mains of SK interact with catalytic domain of Pg, b domain
possesses aﬃnity for kringle domains also. Binding aﬃnity of
isolated SKa domain for Pg is much higher than SAK [20],
therefore, it may be possible that in SK, strong interactions be-
tween a domain and catalytic domain of Pg are forcing the
other two domains to bind next to a to the less favored cata-
lytic domain of Pg, whereas, given a choice, isolated b domain
might prefer to interact with kringle domains of Pg. Since SAK
binding to Pg is not as strong as that of SKa domain, there
might be some competition between SAK and b/bc domains
for binding to preferred sites on Pg after fusion, resulting in
drastically attenuated Pg activation activity of fusion. At-
tempts are underway to engineer the linker region between
SAK and SK domains in SAK fusion proteins to check
whether it is possible to transfer the enhanced cofactor activity
of SAK imparted by the presence of isolated SK domains to
SAK fusion proteins.Acknowledgments: We thank Mr. Muthukrishnan for expert technical
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